Primary UVB-311nm and Adalimumab in Psoriasis Patients
NCT00638261
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
4
Enrollment
OTHER
Sponsor class
Conditions
Psoriasis
Interventions
RADIATION:
UVB-311nm
Sponsor
Medical University of Graz